UMCG and UG aim to functionally accommodate particle accelerator at UMCG
The University of Groningen (UG) and the University Medical Center Groningen (UMCG) intend to connect KVI-CART’s Medical Physics research team to the Radiotherapy Department at the UMCG. It is also the intention to functionally place the AGOR particle accelerator, i.e. with the group of technicians who maintain and operate the facility, within UMCG’s Sector F.
In recent years, the UMCG and the UG, in conjunction with the UMCG Proton Therapy Center, have set up a comprehensive research programme that contributes to the further development of radiotherapy with protons and other ions. The research in radiation biology and radiation physics within this programme makes extensive use of the AGOR particle accelerator (Accélérateur Groningen-ORsay) at the KVI Center for Advanced Radiation Technology (KVI-CART) on the Zernike Campus. Recently, the UMCG and the UG have received substantial funding from KWF (the Dutch Cancer Society) to further develop research in radiation biology for this particle accelerator.
Partly for this reason, the university and the academic hospital have concluded that it is desirable to improve the integration of activities to strengthen research. Prior to final decision-making on the plans, the participation bodies of both institutions (University Council and Works Council) will be consulted in the coming months.
Last modified: | 06 October 2022 09.24 a.m. |
More news
-
02 July 2025
€ 30 million investment for UG spin-off Portal Biotech
Portal Biotech, a pioneer in nanopore-based protein identification and sequencing technology, has raised € 30 million in Series A funding. The funding will support commercial rollout and team growth.
-
01 July 2025
‘Give seals space’
The Wadden Sea is constantly changing. Native animals need to be able to adapt in order to thrive in an environment that is shaped by the tides. By conducting research on seals in the area, PhD students Margarita Méndez-Aróstegui and Beatriz...
-
30 June 2025
David Lentink partners international research project on animal navigation
Prof. David Lentink is a partner in the NaviSense project awarded 54.7 million euros by the German government to research the mechanisms animals use to navigate and how these mechanisms can inspire technology.